These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 26478410)
21. Potential of amorphous microporous silica for ibuprofen controlled release. Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331 [TBL] [Abstract][Full Text] [Related]
22. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Yang YJ; Tao X; Hou Q; Chen JF Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764 [TBL] [Abstract][Full Text] [Related]
23. Mutual interaction between guest drug molecules and host nanoporous silica xerogel studied using central composite design. Li J; Wang H; Li H; Xu L; Guo Y; Lu F; Pan W; Li S Int J Pharm; 2016 Feb; 498(1-2):32-9. PubMed ID: 26657276 [TBL] [Abstract][Full Text] [Related]
24. Regulation role of ibuprofen toward the morphology of porous silica nanospheres during its in situ encapsulation. Du X; He J J Colloid Interface Sci; 2010 May; 345(2):269-77. PubMed ID: 20219205 [TBL] [Abstract][Full Text] [Related]
25. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236 [TBL] [Abstract][Full Text] [Related]
26. Physicochemical characterization, released profile, and antinociceptive activity of diphenhydraminium ibuprofenate supported on mesoporous silica. Wust KM; Beck TS; Burrow RA; Oliveira SM; Brum ES; Brusco I; Machado G; Bianchi O; Villetti MA; Frizzo CP Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110194. PubMed ID: 31923931 [TBL] [Abstract][Full Text] [Related]
27. Low-Field NMR to Characterize the Crystalline State of Ibuprofen Confined in Ordered or Nonordered Mesoporous Silica. Okada K; Hayashi Y; Tsuji T; Onuki Y Chem Pharm Bull (Tokyo); 2022; 70(8):550-557. PubMed ID: 35908921 [TBL] [Abstract][Full Text] [Related]
28. Biologically formed mesoporous amorphous silica. Jensen M; Keding R; Höche T; Yue Y J Am Chem Soc; 2009 Feb; 131(7):2717-21. PubMed ID: 19199622 [TBL] [Abstract][Full Text] [Related]
29. Investigating the Effects of Loading Factors on the In Vitro Pharmaceutical Performance of Mesoporous Materials as Drug Carriers for Ibuprofen. Lai J; Lin W; Scholes P; Li M Materials (Basel); 2017 Feb; 10(2):. PubMed ID: 28772509 [TBL] [Abstract][Full Text] [Related]
30. Novel amorphous microporous silica spheres for controlled release applications. Verraedt E; Van den Mooter G; Martens JA J Pharm Sci; 2011 Oct; 100(10):4295-301. PubMed ID: 21567409 [TBL] [Abstract][Full Text] [Related]
31. Basic evaluation of typical nanoporous silica nanoparticles in being drug carrier: Structure, wettability and hemolysis. Li J; Guo Y Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():670-673. PubMed ID: 28183659 [TBL] [Abstract][Full Text] [Related]
32. Surface Properties of Synthesized Nanoporous Carbon and Silica Matrices. Sterczyńska A; Śliwińska-Bartkowiak M; Zienkiewicz-Strzałka M; Deryło-Marczewska A J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985759 [TBL] [Abstract][Full Text] [Related]
33. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. Shen SC; Ng WK; Chia L; Dong YC; Tan RB J Pharm Sci; 2010 Apr; 99(4):1997-2007. PubMed ID: 19816955 [TBL] [Abstract][Full Text] [Related]
34. Diamine Functionalized Cubic Mesoporous Silica for Ibuprofen Controlled Delivery. Sivaguru J; Selvaraj M; Ravi S; Park H; Song CW; Chun HH; Ha CS J Nanosci Nanotechnol; 2015 Jul; 15(7):4784-91. PubMed ID: 26373038 [TBL] [Abstract][Full Text] [Related]
35. Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance. Schultz HB; Kovalainen M; Peressin KF; Thomas N; Prestidge CA J Pharmacol Exp Ther; 2019 Sep; 370(3):742-750. PubMed ID: 30552294 [TBL] [Abstract][Full Text] [Related]
36. Mesoporous silica material TUD-1 as a drug delivery system. Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183 [TBL] [Abstract][Full Text] [Related]
37. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery. Wang C; He C; Tong Z; Liu X; Ren B; Zeng F Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836 [TBL] [Abstract][Full Text] [Related]
38. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release. Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025 [TBL] [Abstract][Full Text] [Related]
39. Sponge-liked Silica Nanoporous Particles for Sustaining Release and Long-Term Antibacterial Activity of Natural Essential Oil. Lai H; Chen S; Su X; Huang X; Zheng Q; Yang M; Shen B; Yue P Molecules; 2023 Jan; 28(2):. PubMed ID: 36677650 [TBL] [Abstract][Full Text] [Related]
40. Estimating the solubility of amorphous ibuprofen using nanoporous anodic aluminum oxide as a solidification template. Lee SY; Yu G; Shin K; Kim IW J Nanosci Nanotechnol; 2013 Mar; 13(3):2348-53. PubMed ID: 23755690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]